Cargando…
Portopulmonary hypertension in cirrhotic patients: Prevalence, clinical features and risk factors
The incidence and clinical features of portopulmonary hypertension (POPH) have not been adequately described and it is currently unknown whether an association exists between the severity of POPH and liver function. Additionally, POPH risk factors are yet to be identified. The aim of this study was...
Autores principales: | CHEN, HUI-SONG, XING, SU-RONG, XU, WEI-GUO, YANG, FAN, QI, XIAO-LONG, WANG, LE-MIN, YANG, CHANG-QING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570126/ https://www.ncbi.nlm.nih.gov/pubmed/23403613 http://dx.doi.org/10.3892/etm.2013.918 |
Ejemplares similares
-
Portopulmonary hypertension
por: Saleemi, Sarfraz
Publicado: (2010) -
Prevalence and Clinical Features of Portopulmonary Hypertension in Patients With Hepatic Cirrhosis: An Echocardiographic Study
por: Gupta, Anany, et al.
Publicado: (2022) -
Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients
por: Li, Jian, et al.
Publicado: (2018) -
Portopulmonary Hypertension: An Updated Review
por: Jasso-Baltazar, Erick A., et al.
Publicado: (2023) -
Natural killer cell-mediated immune deficiency or compromise in patients with portopulmonary hypertension
por: Chen, Huisong, et al.
Publicado: (2014)